Dr. Wilbur Leopold, president of Molecular Imaging Research, Inc., a Michigan based corporation, today announced the company will do business as MIR Preclinical Services. The Company is a contract research organization (CRO) specializing in the preclinical evaluation of novel anti-tumor agents.
